Oscar Health (NYSE:OSCR) Downgraded by Wells Fargo & Company to “Equal Weight”

Wells Fargo & Company lowered shares of Oscar Health (NYSE:OSCR) from an overweight rating to an equal weight rating in a research report sent to investors on Thursday, Marketbeat.com reports. They currently have $16.00 target price on the stock, down from their previous target price of $20.00.

Separately, Jefferies Financial Group began coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Oscar Health presently has an average rating of “Hold” and a consensus price target of $20.19.

Oscar Health Trading Down 9.1 %

NYSE:OSCR opened at $12.91 on Thursday. The stock has a market cap of $3.23 billion, a price-to-earnings ratio of -644.93 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health has a 1 year low of $12.43 and a 1 year high of $23.79. The business has a fifty day moving average of $15.23 and a 200-day moving average of $16.43.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Equities analysts predict that Oscar Health will post 0.69 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. KBC Group NV boosted its position in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares during the period. Tower Research Capital LLC TRC lifted its position in Oscar Health by 171.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock worth $89,000 after buying an additional 4,185 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health during the 4th quarter valued at $100,000. Aigen Investment Management LP purchased a new position in shares of Oscar Health during the 3rd quarter valued at $205,000. Finally, Alberta Investment Management Corp acquired a new position in shares of Oscar Health in the fourth quarter worth $138,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.